Clinical Trial Update: The TRUST Trial - CardioVascular Imaging ECHO [Phase 4]

View source ↗

Summary

This Phase 4 update reports the TRUST trial (CardioVascular Imaging ECHO) has completed, investigating thyroid dysfunction, atherosclerosis, and heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Heart Failure
• Thyroid Dysfunction

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Thyroid Dysfunction, Atherosclerosis | Phase 4 | Status: COMPLETED